Hikma Pharmaceuticals PLC
1987,00
31-июля-25 04:25:32
15 мин. задержка
Акции
-3,00
-0,15%
Сегодняшний диапазон
1986,00 - 2001,00
ISIN
N/A
Источник
Cboe
- Котировки
- Графики
Новости
- Статистика
-
Hikma Pharma Announces Launch Of Morphine Sulfate Injection In The US
14 июл 2025 02:25:12 Источник NASDAQ US Markets
-
Bio-Thera Solutions And Hikma Pharma Say FDA Approved STARJEMZA Injection
26 май 2025 23:43:27 Источник NASDAQ US Markets
-
Hikma Pharma Reaffirms FY25 Guidance Amid Strong Start
24 апр 2025 00:54:25 Источник NASDAQ US Markets
-
Axsome Settles Patent Litigation With Hikma Related To Sunosi - Quick Facts
05 мар 2025 04:55:56 Источник NASDAQ US Markets
-
Hikma Pharma Inks Exclusive Commercial Deal With Emergent BioSolutions For KLOXXADO Nasal Spray 8 Mg
14 янв 2025 05:49:06 Источник NASDAQ US Markets
-
Hikma Pharma Extends Recall Of Acetaminophen Injection
23 июл 2024 00:11:57 Источник NASDAQ US Markets
-
Hikma Pharma To Acquire Parts Of Xellia Pharma's US Finished Dosage Form Business And Assets
16 июн 2024 23:45:01 Источник NASDAQ US Markets
-
Collegium Pharma Partners With Hikma For Authorized Generics Of Nucynta In US
29 апр 2024 06:07:49 Источник NASDAQ US Markets
-
Hikma Pharma FY Profit Increases
22 фев 2024 00:52:27 Источник NASDAQ US Markets
-
Hikma Pharma Launches Pain Relief Injection COMBOGESIC IV In US
05 фев 2024 04:48:52 Источник NASDAQ US Markets
-
Guardant Health, Hikma To Offer Cancer Screening & Genomic Profiling Tests In Middle East & Africa
08 янв 2024 00:35:52 Источник NASDAQ US Markets
-
Hikma Pharmaceuticals (LSE:HIK) Price Target Increased by 9.63% to 2,311.15
31 авг 2023 22:51:58 Источник NASDAQ Stocks
-
Hikma Pharma H1 Profit Down, Revenues Up; Lifts FY23 Forecast For Generics
03 авг 2023 00:46:32 Источник NASDAQ US Markets
-
Barclays Reiterates Hikma Pharmaceuticals (LSE:HIK) Equal Weight Recommendation
04 май 2023 17:30:46 Источник NASDAQ Stocks
-
Hikma Pharma Appoints Riad Mishlawi As CEO, Effective Sept. 1
11 апр 2023 23:25:53 Источник NASDAQ US Markets
-
Hikma Pharma FY22 Results Down, Lifts Dividend; Says Confident Of FY23 Growth; Stock Up
23 фев 2023 01:10:05 Источник NASDAQ US Markets
-
Hikma accuses Amarin of suppressing generic versions of heart pill
22 фев 2023 14:13:30 Источник NASDAQ US Markets
-
Hikma Pharma Launches Authorized Generic Version Of Xyrem In U.S.
03 янв 2023 00:15:34 Источник NASDAQ US Markets
-
Hikma Pharma Says Not Signed Licensing Agreement With Opiant Pharma
29 апр 2022 20:58:14 Источник NASDAQ US Markets
-
U.S. FTC approves Hikma deal for Custopharm with conditions
19 апр 2022 11:04:52 Источник NASDAQ US Markets
- <<
- <
- 1
- >